Ticker
IGMSCompany Name
IGM BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 76.57M | $ 1.64M | $ 0 | $ 0 | -2.14% |
3/31/2025 | $ 69.13M | $ 2.27M | $ 0 | $ 0 | -3.29% |
12/31/2024 | $ 83.69M | $ 2.46M | $ 0 | $ 0 | -2.94% |
9/30/2024 | $ 774.82M | $ 2.44M | $ 0 | $ 0 | -0.32% |
6/30/2024 | $ 517.26M | $ 45.88M | $ 0 | $ 0 | -8.87% |
3/31/2024 | $ 551.28M | $ 115.18M | $ 0 | $ 0 | -20.89% |
12/31/2023 | $ 713.08M | $ 115.07M | $ 0 | $ 0 | -16.14% |
9/30/2023 | $ 271.53M | $ 115.15M | $ 0 | $ 0 | -42.41% |
6/30/2023 | $ 554.47M | $ 70.81M | $ 0 | $ 0 | -12.77% |
3/31/2023 | $ 559.39M | $ 219.32M | $ 0 | $ 0 | -39.21% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for IGM BIOSCIENCES INC is calculated as follows: (-1 * CF - Equity [ $ 374K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.5B ]
(=) Shareholder Yield [ -0.02% ]
Minimum
Sep 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |